To say that Neuros Medical (Cleveland) has been busy as of late would be an understatement. The firm is focused on raising money for a Series B funding round; just received an Investigational Device Exemption for its Altius product, which delivers high frequency electrical nerve block technology for patients suffering from chronic pain; and released results of a pilot study on the device.